Cyclosporin A has proved to be a valuable drug both in the prevention of graft rejection after solid organ transplantation' and in the prevention of graft versus host disease after bone marrow transplantation.2 Caine et al treated the first cadaver renal allograft recipients with cyclosporin A in 1978,3 and toxicity due to the drug was noted soon afterwards. The adverse effects in transplant recipients attributed to cyclosporin are numerous, with renal and hepatic toxicity and tremor being well described.
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Convulsions associated with cyclosporin A in renal transplant recipients M BEAMAN, S PARVIN, P S VEITCH, J WALLS Cyclosporin A has proved to be a valuable drug both in the prevention of graft rejection after solid organ transplantation' and in the prevention of graft versus host disease after bone marrow transplantation.2 Caine et al treated the first cadaver renal allograft recipients with cyclosporin A in 1978,3 and toxicity due to the drug was noted soon afterwards. The adverse effects in transplant recipients attributed to cyclosporin are numerous, with renal and hepatic toxicity and tremor being well described.
We report three cases of neurotoxicity presenting with grand mal seizures in renal transplant recipients which we believe to have been associated with cyclosporin A.
Case 1 A 32 vear old man with chronic renal failure due to chronic pyelonephritis underwent cadaveric renal transplantation in November 1983. He was normotensive at the time of operation. Immunosuppression was provided by cyclosporin A 17 mglkg/day in divided doses, reducing to 15 mg/kg/day after two weeks, and prednisolone starting at 100 mg/day and reducing by 10 mg increments daily to 30 mg/day. On day 24 after transplantation he presented with right sided headache and blurred vision. He had vomited several times that day and on examination his blood pressure was 160/100 mm Hg. Drug treatment at that time included cyclosporin A 15 mg/kglday, prednisolone 30 mg/day, and cimetidine 200 mg twice daily. He was not feverish, had no graft tenderness, and there were no other abnormal physical signs. Results of investigations were: haemoglobin concentration 7-7 g/dl, white cell count 11 7x109/1, and serum concentration of creatinine 440 Ftmoll1 (50 mg/100 ml; serum creatinine value had been slowly falling since transplantation), urea 35 5 mmol/1 (214 mg/100 ml), sodium 143 mmol(mEq)/I, potassium 6 4 mmol(mEq)/1, and glucose 8-5 mmol/l (153 mgl100 ml).
The next day he became disorientated in time and progressively drowsy and after a few hours he was unresponsive to painful stimuli. He then had a grand mal seizure lasting two minutes and affecting all limbs. Intubation and intermittent positive pressure ventilation were required. CT brain scan was normal and lumbar puncture yielded the following results: pressure 23 cm water, red blood cells 31 000/1, white blood cells 3000x 10611, and concentration of protein 0C1 g/l and glucose 6-9 mmol/1 (124 mg/100 ml) (blood glucose 10-3 mmoll1; 186 mg/100 ml). sequelae and no further seizures. Cyclosporin A was reintroduced at 5 mg/kg/day five days later when his serum creatinine concentration had fallen to 240 !tmol/l (2-7 mg/100 ml).
Case 2
A 38 year old man with chronic renal failure due to chronic glomerulonephritis underwent cadaveric renal transplantation in April 1983. His hypertension was controlled with propranolol 80 mg twice daily before transplantation. He was immunosuppressed with azathioprine and prednisolone 10 mg on alternate days at the time of presentation.
Within four weeks of transplantation he had two rejection episodes managed by high dose steroids (methylprednisolone 1 g daily for three days) and radiotherapy to the graft. Nine months after transplantation his serum creatinine concentration rose from a stable 200 Ftmol/l (2 3 mg/100 ml) to 400 FtmoL/l. Renal biopsy showed cellular rejection and he was treated with methylprednisolone 0-5 g for three consecutive days with only a temporary effect. In an attempt to halt the rejection process cyclosporin A was instituted at 17 mg/kg/day together with prednisolone 15 mg on alternate days.
Twelve days after starting cyclosporin A he was admitted to hospital complaining of "flashing lights" in the right visual field, nausea, headache, and incoherent speech. Blood pressure was 230/110 mm Hg. No focal neurological signs were present and his fundi were normal. He had a grand mal seizure shortly after admission, affecting all limbs and lasting three minutes.
The cyclosporin A was stopped and within 24 hours he felt well again and showed no residual neurological sequelae. A CT brain scan was normal; lumbar puncture was not performed in view of his rapid recovery. Results of other investigations included: haemoglobin concentration 12-3 g/dl, white cell count 9 3 x 109/1, and serum concentration of creatinine 610 Ftmol/l (6-9 mg/100 ml), urea 20-2 mmol/l (122 mg/100 ml), sodium 134 mmol/l, potassium 4-3 mmol/l, and blood glucose 7-7 mmol/l (139 mg/100 ml). His cyclosporin A concentration was 1583 tg/l at the time of the seizure. Cyclosporin A was reintroduced after 48 hours at 5 mg/kg/day, his serum creatinine value having fallen to 450 limol/l (5-1 mg/100 ml). He remained well until six weeks after transplantation, when he had a grand mal seizure lasting five minutes. At the time of admission blood Therapeutic doses of cyclosporin A given to adults with solid organ transplants may precipitate grand mal seizures; vigilance when using this drug should include regular monitoring of the serum concentrations pressure was 125/90 mm Hg and temperature 38-9°C. The left pupil was larger than the right but both reacted normally to light and accommodation. There was a small herpes simplex lesion on his lower lip. After admission he had a further grand mal seizure, again lasting five mriinutes.
Results of investigations were: serum concentration of creatinine 160 !tmol/l (1-8 mg/100 ml), urea 17 3 mmoL'l (104 mg/100 ml), sodium 134 mmol/l, and potassium 4-98 mmol/l; haemoglobin concentration 9-3 g/dl; platelet count 386x 109/1, and chest x ray picture normal. A CT brain scan showed the area of low density secondary to the old subdural haematoma. Lumbar puncture results were: pressure 20 cm water, red blood cells 3000/1, white cells nil, protein concentration <0 1 g/l, and glucose 3 1 mmol/l (56 mg/l00 ml) (blood glucose 5 1 mmol/l; 92 mg/100 ml).
His medication included atenolol 100 mg daily, prednisolone 20 mg daily, and cyclosporin A 10 mg/kg/day. The serum cyclosporin A value iM-Mediately before his first seizure was 690 tg/l. No evidence of bacterial or fungal infection was found. The only viral antibody titre to be raised was that to herpes simplex, rising from 1/64 one month before admission to 1/128 on the day of admission.
Cyclosporin A was stopped for 48 hours and then reintroduced at the same dose. After stopping cyclosporin A his temperature was normal and he was clinically well with no residual neurological signs apart from the unequal pupils, which were of long standing. The serum creatinine concentration had fallen to 110 [tmol/l (1 2 mg/100 ml).
Comment
Reported neurotoxic manifestations of cyclosporin A include tremors, ataxia, muscle weakness, paraesthesia, and seizures.46 There have been few reports of seizures in adults associated with cyclosporin A in renal transplantation, and most individual cases described have been in children after bone marrow transplantation. In both reports of seizures with renal transplantation7' the actual cyclosporin A concentrations at the time of the seizure were not given, and in the second report the seizures were associated with malignant hypertension.
The rapid improvement in the general condition of our three patients and the reduction in serum creatinine concentrations seen during the recovery period suggest that these represent examples of cyclosporin A related seizures. Where the surgical procedures mentioned in the algorithm fit into the schedule of infertility investigations is open to argument. Many gynaecologists do them early. A sensible approach is to get patients on to the waiting list soon but not hold up the rest of the investigations until the surgery has been performed. With any luck the patient will be pregnant by the time her turn comes. A history suggestive of endometriosis or pelvic sepsis puts tubal investigaUniversity Department of Obstetrics and Gynaecology, Royal Infirmary, Aberdeen AB9 2ZB ARNOLD KLOPPER, FRCOG. professor of reprodtuctive endocrinology tion high on the list. Tubal blockage may be suitable for surgery if the tubal damage is minimal, but badly blocked or damaged tubes are not amenable to surgery. Irreparable tubal blockage was the original indication for in vitro fertilisation. Nowadays subfertile male infertility or unexplained infertility is a commoner and a more rewarding indication.
Among patients who do not have tubal blockage, those with an inadequate luteal phase, menopause praecox, or unexplained infertility present the greatest problems. The results of treatment for an inadequate luteal phase are disappointing. If clomiphene or clomiphene plus chorionic gonadotrophin is given at ovulation it is not difficult to raise progesterone concentrations to the values found in conceptual cycles, but this seldom results in pregnancy.
In patients with menopause praecox treatment is useless. Persuade the patient kindly but very firmly that prognosis is hopeless and that none of tomorrow's great discoveries will be of any avail.
Unexplained infertility is a mixed bag of conditions that are difficult to diagnose. Autoimmunitv or an immune reaction by the
